Please assess the completion status of the following clinical trial:

Trial Title: Statin/Vitamin D & Migraine Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18 years or older~* Have had migraines for at least 3 years~* Have between 4 and 15 migraines a month~* Able to speak and read the English language~Exclusion Criteria:~* Women who are pregnant or nursing, or planning on becoming pregnant in the next 10 months~* Individuals who have a had a heart attack, stroke, peripheral artery disease, atherosclerotic aortic disease, carotid artery disease, or diabetes~* individuals at high risk for cardiovascular disease

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Simvastatin and vitamin D (Type: EXPERIMENTAL): Participants in this arm will receive simvastatin + vitamin D.
- Placebo Sugar Pill (Type: PLACEBO_COMPARATOR): Participants in this arm will take placebo pills, which look like the simvastatin and vitamin D. A placebo pill has no active medication in it, and is like taking a sugar pill.

Based on this trial design, predict the completion outcome and termination type (if applicable).